WilmerHale is proud to sponsor the 17th Annual Summit on Biosimilars & Innovator Biologics. Partner Kevin Prussia will speak at the “Biosimilars and Innovator Biologics Year in Review” session addressing the evolving legal, regulatory and commercial landscape impacting biosimilars and next generation biologics. The panel will provide a comprehensive review of the most significant developments from the past year and examine what lies ahead in 2026 and beyond.
We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.
